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LPS-Induced Migration of Peritoneal B-1 Cells is Associated with 
Upregulation of CXCR4 and Increased Migratory Sensitivity to 
CXCL12
B-1 cells, which constitute a predominant lymphocyte subset in serosal cavities and 
produce most of natural antibodies, are subdivided into the CD5
+ B-1a and CD5
- B-1b cell 
subpopulations, but the differential roles of B-1a and B-1b cells are not well understood. 
We report that B-1a cells preferentially migrate out of the peritoneal cavity and upregulate 
the expression of CXCR4 with heightened sensitivity to CXCL12 and CXCL13 upon LPS 
treatment compared to B-1b and B-2 cells. Whereas B-1a cells were slightly more 
abundant than B-1b and B-2 cells in the homeostatic condition, the number of B-1a cells 
preferentially decreased 48 hr after LPS treatment. The decrease in the peritoneal B-1a cell 
number was accompanied with increased migration of B-1a cells toward CXCL-12 and 
CXCL-13 in in vitro transmigration assay using peritoneal B cells from LPS treated mice. The 
expression level of CXCR4, but not of CXCR5, was also more prominently increased in B-1a 
cells upon LPS stimulation. LPS-stimulated B-1a cells did not accumulate in omental milky 
spots in contrast to B-2 cells. These results suggest that B-1a cells actively migrate out of 
the peritoneal cavity through the regulation of the migratory responsiveness to chemokines 
and actively participate in systemic immune responses.
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INTRODUCTION
 
B-1 cells are innate B cells that are distinguished from follicular 
B-2 cells by their cell surface phenotype, anatomical localization, 
self-renewal, and functional properties (1, 2). Although B-1 cells 
are a minor population of B cells, they produce more than 80% 
of circulating natural IgM that play a critical role in host defense 
against common infections. Characteristically, B-1 cells are found 
in the peritoneal and other serosal cavities and express a high 
level of IgM, a low level of IgD, and CD11b on their cell surface. 
B-1 cells are divided into CD5-bearing B-1a cells and CD5-neg-
ative B-1b cells, which develop from distinct progenitor cells. 
While follicular B-2 cells and B-1b cells develop from adult he-
matopoietic progenitors in bone marrow, B-1a cells develop early 
in the neonate from fetal hematopoietic progenitors in fetal liver 
(3). Functionally, B-1a cells are thought to be responsible for 
spontaneously generated natural antibodies and B-1b cells were 
reported to constitute a T cell-independent humoral memory 
(4), but differential functions of B-1a and B-1b cells are not clear-
ly understood. 
  Besides the natural antibody production, B-1a cells are also 
reported to be involved in systemic immune responses such as 
delayed type hypersensitivity or alloimmune response (5, 6). 
B-1a cells were constantly found in blood compartment and 
required the spleen for their maintenance (7). These findings 
suggest that B-1a cells are constantly circulating in the body at a 
low speed although most of B-1a cells reside in the serosal cavi-
ty and that B-1a cells are dynamically mobilized upon systemic 
inflammatory events. However, it is not known well how B-1a 
cells are localized in the peritoneal cavity and migrate from the 
peritoneal cavity and enter the peripheral sites and whether 
B-1b cells behave similarly or not.
  Chemokines are a family of small cytokines or proteins secret-
ed by various types of cells and defined by their ability to trigger 
the tissue-specific targeting of leukocytes (8). Chemokine and 
chemokine receptors are participating in the recruitment of cells 
into the lymphoid organs and in the egress of cells from the lym-
phoid tissues (9). Homing of B cells to lymphoid follicles princi-
pally depends on expression of CXCR5 by B cells and produc-
tion of CXCL13 (B lymphocyte chemoattractant), the ligand for 
CXCR5, by radiation-resistant follicular stromal cells (10). CXCR5 
is upregulated during B cell development and is expressed by 
all mature B cells including B-1 cells (11). For B-1 cell localiza-
tion, CXCR5 and CXCL13 does not explain why B-1 cells are not Moon H, et al.  •  LPS-induced Migration of B-1 Cells
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localized in the lymphoid follicle, but retained in the peritoneal 
cavity. Another important chemokine for B cell function is CXCL12 
(stromal cell-derived factor-1), which binds to CXCR4. CXCL12 
has functions other than the chemotaxis, in that it supports sur-
vival of precursor B cells and B cell development (12, 13). The 
studies on CXCR4 signaling implicates that CXCR4 has differ-
ential signaling pathways leading to cell survival or chemotaxis, 
suggesting that different effects of CXCL12 depend on develop-
mental or activation status (14). Since CXCL12 is produced by 
peritoneal mesothelial cells, it is likely that the CXCL12-CXCR4 
pathway is responsible for the survival and localization of B-1 
cells (15, 16).
  In the current study, we investigated whether the innate im-
mune stimulation of B-1 cells with lipopolysaccharide (LPS) 
change their migratory behaviors and found that B-1 cells en-
hanced the capability to migrate in response to CXCL12 and 
CXCL13 upon LPS stimulation. Unexpectedly, we also observed 
that B-1a cells were characteristically different from B-1b and 
B-2 cells in their migratory behavioral changes upon LPS stim-
ulation.
 
MATERIALS AND METHODS
Animals and agents
C57BL/6 mice were purchased from Orient Bio (Sungnam, Korea), 
maintained, and used according to institutional guidelines in a 
pathogen-free facility. This study was reviewed and approved 
by the institutional animal care and use committee (IACUC) of 
Sungkyunkwan University School of Medicine (Permission No. 
10-31), which is an Association for Assessment and Accredita-
tion of Laboratory Animal Care International (AAALAC Interna-
tional) accredited facility and abide by the Institute of Labora-
tory Animal Resources (ILAR) guide.
  Mouse recombinant CXCL12, CXCL13, and anti-mouse 
CXCL12 antibody were purchased from the R&D systems (Min-
neapolis, MN, USA).
LPS treatment and collection of peritoneal and omental 
cells
Eight to ten week old C57BL/6 mice were injected intraperito-
neally with 100 μg of LPS (Sigma Aldrich, St. Louis, MO, USA). 
After 48 hr, peritoneal cells were isolated by flushing the perito-
neal cavity with 8 mL of phosphate buffered saline (PBS). Omen-
tal cells were isolated after mincing through nylon mesh. Cells 
were washed twice in PBS with 5% bovine calf serum (BCS), 
0.05% sodium azide for flow cytometric analysis. The exact num-
bers of cells were determined by calculating the total number 
based on the number of cells per ml corrected for the volume 
injected and volume recovered and analyzing of flow cytomer-
tic data. 
  For in vitro studies, peritoneal cells of C57BL/6 mice were sus-
pended in serum-free RPMI 1640 culture medium, supplement-
ed with 25 mM sodium bicarbonate, 2 mM glutamine, 50 U/mL 
of penicillin, 50 μg/mL of streptomycin, and 10 mM HEPES (all 
reagents are from Invitogen Gibco, Carlsbad, CA). Then, perito-
neal cells were incubated for 24 hr with or without 10 μg/mL 
LPS and then were used for flow cytometric analysis. 
Flow cytometric analysis
For analysis of B cell subsets, peritoneal cells and omental cells 
were stained on ice for 15 min with combinations of following 
fluorochrome-conjugated antibodies in PBS with 5% BCS, 0.05% 
sodium azide. Antibodies against B220 (RA3-6B2), CD19 (1D3), 
and CXCR5 (2G8) were from BD Biosciences (San Jose, CA, USA); 
antibodies against IgM (II/41) and CXCR4 (2B11) from eBiosci-
ence (San Diego, CA, USA); and antibodies against CD5 (53-7.3) 
and CD11b (M1/70) from BioLegend (San Diego, CA, USA). After 
washing with PBS, the stained cells were analyzed on a FACS-
CantoII (BD Biosciences). In all cases, doublets were excluded 
based on forward scatter area versus height gating.
Transwell migration assay 
Peritoneal B cells labelled with anti-CD19 magnetic beads were 
purified with the use of MACS (Miltenyi Biotec, Auburn, CA, 
USA) and used for transwell migration assay. Purified B cells 
were resuspended in serum-free RPMI 1640 culture medium. 
0.5-1 × 10
6 cells in 100 μL medium were loaded into the upper 
chamber of 5 μM pore size transwell (Corning Costar, Cam-
bridge, MA, USA). The lower wells were filled with 600 μL of 
medium either with or without 100 ng/mL CXCL12 or CXCL13. 
Cells that migrated into the lower chambers were harvested af-
ter 2 hr of incubation and counted by flow cytometry.
ELISA
Plates were coated with purified anti-CXCL12 and blocked with 
PBS containing 1% BSA. Bound CXCL12 was detected biotinyl-
ated anti-mouse CXCL12 antibody, followed by horseradish 
peroxidase-Streptavidin (BD Biosciences) and subsequent de-
velopment with substrate (eBioscience).
Statistical analysis
Student t test was used to assess statistical significance and P 
value of  < 0.05 was considered statistically significant for all 
tests. Histogram was plotted with GraphPad Prism 4.0 program 
(GraphPad Software, San Diego, CA, USA).
 
RESULTS
Preferential migration of B-1a cells out of peritoneal cavity 
upon LPS stimulation
B-1a and B-1b cells are mainly localized in the peritoneal cavity, 
but B-2 cells are also found in this compartment. To investigate Moon H, et al.  •  LPS-induced Migration of B-1 Cells
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whether LPS stimulation changes the proportion of B cell sub-
sets in the peritoneal cavity, we accurately enumerated the num-
bers of B cell subsets in the resting state and 24 or 48 hr after in-
traperitoneal LPS injection. In the homeostatic condition, B-1a 
cells outnumbered B-1b and B-2 cells (Fig. 1). LPS stimulation 
led to transient decrease in numbers of all B cell subsets in 24 hr, 
but the numbers of peritoneal B-2 and B-1b cells recovered near-
ly to those in the homeostatic condition in 48 hr. Characteristi-
cally, the number of peritoneal B-1a cells did not recover to that 
in the homeostatic condition in 48 hr (Fig. 1B). The decrease in 
the B-1a cell number upon LPS stimulation was statistically sig-
nificant in 24 and 48 hr. Reflecting differential migration of B-1a 
and B-1b cells, the relative ratio of B-1a cells versus B-1b cells 
was reversed in 48 hr after LPS injection (Fig. 1A). These findings 
suggest that the peritoneal B-1a cells have migratory character-
istics distinct from those of B-1b cells or B-2 cells. 
Preferential increase of the migratory capability of LPS-
stimulated B-1a cells toward CXCL12 
To prove into the mechanism of differential migration of perito-
neal B cell subpopulations, we checked migratory responsive-
ness of resting or LPS-activated B cells to CXCL12 and CXCL13, 
representative B cell-attracting chemokines, and the expression 
of their receptors. Peritoneal B cells were purified from mice 
treated with PBS or LPS for 24 hr or 48 hr and then were used 
for transwell migration assay. We performed flow cytometric 
analysis to determine the ratios of B cell subsets in input and 
transmigrated cells and calculated the percentage of migration 
for each B cell subset (Fig. 2). B-2 cells from PBS-treated mice 
transmigrated efficiently toward CXCL12 and CXCL13, but B-1a 
and B-1b cells migrated poorly toward CXCL12 with showing 
relatively fine migration toward CXCL13, suggesting that the ca-
pability of migration toward CXCL12 is differentially regulated in 
B cell subsets. The migratory responses to CXCL12 and CXCL13 
were all greatly increased in all B cell subsets from LPS-treated 
mice, but the time-dependent changes of migratory responses 
for three B cell subsets were different. For B-2 cells, the migra-
tion of B-2 cells toward CXCL-12 and CXCL-13 increased in 24 
hr upon LPS treatment, but B-2 cells from 48 hr LPS treatment 
showed lower migration capability to a level of that of homeo-
static B-2 cells. Noticeably, B-1a cell migratory responsiveness 
to CXCL12 and CXCL13 increased significantly after 48 hr LPS 
treatment and B-1b cells from LPS-treated mice migrated to an 
intermediate level between those of B-1a and B-2 cells. 
  The changes of B-1 cell responses to CXCL12 and CXCL13 
were also observed in in vitro LPS stimulation (Fig. 3). Here B 
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Fig. 1. LPS induces the preferential egress 
of peritoneal B-1a cells. (A) Peritoneal 
cells obtained from 10 week-old C57BL/6 
mice at the indicated time after intraperi-
tioneal injection of LPS were stained with 
fluorescence labeled anti-IgM, -B220, 
-CD11b, and -CD5 and were analyzed 
by flow cytometry. In all cases, doublets 
were excluded by forward scatter area vs 
height histogram. B-2 cells were gated 
based on B220
high and IgM
low expression 
and B-1 cells were gated based on and 
IgM
high expression. (B) At the indicated 
times after LPS injection, the absolute 
numbers of indicated cells in the perito-
neal cavity were calculated from the total 
cell number and flow cytometric data. 
Representative flow cytometric data from 
three mice of each treatment group were 
shown in (A). Statistical analysis was per-
formed by Student’s t test in comparison 
with the numbers of PBS treatment group. 
n.s., differences not statistically signifi-
cant. *P = 0.01-0.05; 
†P = 0.001-0.01.Moon H, et al.  •  LPS-induced Migration of B-1 Cells
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cells were purified and then stimulated in vitro with LPS and 
transwell migration assays were performed with B cells with or 
without stimulation. Here again the responses of resting B-1a 
cells to CXCL-12 were lower than that of resting B-2 cells although 
responses to CXCL-13 were comparable. Consistent with in vivo 
LPS stimulation results, LPS stimulation increased the migrato-
ry response of B-1a cells toward CXCL-12 to a level of that of 
B-2 cells. 48 hr LPS stimulation experiments could not be per-
formed since the surface expression of Mac-1 was lost in B-1 
cells and thus B-1 cells could not be defined in in vitro culture. 
These findings suggest that the switch of B-1a cell responses to 
CXCL-12 and CXCL13 upon LPS treatment may be responsible 
for the selective migration of B-1a cells.
Greater upregulation of CXCR4 in LPS-stimulated B-1a 
cells than in B-1b and B-2 cells 
We next investigated whether the enhancement of the B cell 
migration toward CXCL12 and CXCL13 upon LPS stimulation 
was accompanied by the upregulated expression of CXCR4 and 
CXCR5 (Fig. 4). The expression levels of CXCR4 and CXCR5 were 
comparable among three B cell subsets in the resting condition. 
Upon LPS treatment, the expression of CXCR4 increased greatly 
with time and reached to a peak level in 24 hr and then returned 
to the basal expression level in 48 hr. The upregulation of the 
CXCR4 expression upon LPS treatment was most prominent in 
B-1a cells and the lowest in B-2 cells. In contrast, the the expres-
sion of CXCR5 was upregulated very rapidly in 3 hr upon LPS 
treatment and declined to a level even lower than that in the rest-
ing condition in 48 hr. The expression levels of S1P receptors in 
B-1 cells were not altered by LPS stimulation (data not shown). 
The results suggest that the increased migratory responsiveness 
of B-1a cells to CXCL12 upon LPS stimulation may be due to 
the increased expression of CXCR4, but this cannot explain the 
increased responsiveness to CXCL13 since the responsiveness 
to CXCL13 was not corresponding to the expression level of its 
receptor, CXCR5. 
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Fig. 2. Heightened migratory response of peritoneal B cells obtained from LPS-treated mice in response to CXCL12 or CXCL13. In vitro transwell migration assay was per-
formed with peritoneal B cells isolated from 10 week-old C57BL/6 mice at the indicated time after intraperitioneal injection of LPS. Peritoneal B cells were added to the upper 
chamber of a transwell plate in the presence of CXCL12 or CXCL13 in the lower chamber. Two hour later, the numbers of B-1a, B-1b, and B-2 cells in the lower chambers were 
counted. Results represent the percentage of the cell number in the lower chamber over the input number in response to medium alone, CXCL12, or CXCL13. Data were col-
lected from three mice each experimental group. Statistical analyses were performed by Student’s t test for comparison between groups of treatment with PBS and LPS (24 
and 48 hr) (above each bar) and also between B-1a cells and B-2 cells or B-1b cells (above each drawn line). n.s., differences not statistically significant. *P = 0.01-0.05; 
†P = 
0.001-0.01. 
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Fig. 3. Increased chemotactic response of LPS-stimulated 
peritoneal B cells in response to CXCL12 or CXCL13. In vitro 
migration assay was performed with purified peritoneal B cells 
stimulated for 24 hr with or without LPS in vitro. Peritoneal B 
cells were added to the upper chamber of transwell plate in 
the presence of CXCL12 or CXCL13 in the lower chamber.   
2 hr later, the numbers of B-1a, B-1b, and B-2 cells in the 
lower chambers were counted. Results represent the per-
centage of the cell number in the lower chamber over the in-
put number in response to medium alone, CXCL12, or CXCL13. 
Statistical analyses from three mice of each experimental 
group were performed by Student’s t test in comparison with 
the group of media treatment. n.s., differences not statisti-
cally significant. *P = 0.01-0.05; 
†P = 0.001-0.01.Moon H, et al.  •  LPS-induced Migration of B-1 Cells
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  The change of expression of chemokine receptors was also 
investigated in in vitro LPS-stimulated B cells. Here the propor-
tion of B-1a cells over B-1b cells did not change by 24 hr in vitro 
culture with LPS (Fig. 5A). The increased expression of CXCR4 
by in vitro culture with LPS was most prominent in B-1a cells, 
whereas upregulation of CXCR5 expression upon LPS stimula-
tion was not significantly different among B cell subsets (Fig. 5B). 
These results suggest that B-1a cells respond more sensitively to 
LPS by the increased chemotaxis toward CXCL12 and the up-
regulated expression of CXCR4 than B-1b and B-2 cells.
No change of peritoneal CXCL12 production upon LPS 
treatment
Previously, it was reported that CXCL12 concentration was sig-
nificantly produced by steady-state mesothelial cells (15) and, 
therefore, it is likely that B-1 cells stay in the peritoneal cavity 
through the CXCL12-CXCR4 pathway in the homeostatic con-
dition. To test whether the decreased production of CXCL12 by 
mesothelial cells upon LPS treatment explain for the migration 
of peritoneal B cells, we measured concentrations of CXCL12  
in peritoneal fluids from mice with or without LPS treatment by 
ELISA. 
  Concentrations of CXCL12 did not significantly change upon 
LPS treatment (Fig. 6). These findings suggest that B-1a cells mi-
grate out of the peritoneal cavity through the intrinsic regulation 
of their responsiveness to CXCL12, not through the B cell-extrin-
sic regulation of CXCL12 production.
Fig. 4. Time-course expression of CXCR4 and CXCR5 in peritoneal B cell subsets upon LPS treatment. (A) Peritoneal cells isolated from 10 week-old C57BL/6 mice at the indi-
cated time after intraperitioneal injection of LPS were stained with fluorescence labeled anti-IgM, -CD11b, -CD5, -CXCR4, and -CXCR5 and and were analyzed by flow cytometry. 
Histograms show mean fluorescence intensities (MFI) of surface CXCR4 (upper panel) and CXCR5 (lower panel). (B) Kinetics of the time-dependent expression of surface CXCR4 
(left) or CXCR5 (right) on given peritoneal B cell subsets from C57BL/6 mice treated with LPS for given time duration.
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B-1a cells do not migrate into the omental milky spots 
upon LPS treatment
The omental milky spots (OMSs) are the lymphoid compartment 
connecting between the systemic circulation and the peritoneal 
cavity, where the interaction among lymphoid cells occur dur-
ing peritoneal inflammation (17). Therefore, we tested whether 
B cell subpopulations migrated to this compartment upon LPS 
treatment. When we analyzed B cell subsets in OMSs by flow 
cytometry, we found that the number of B-1a as well as B-1b 
cells in OMSs were significantly decreased upon LPS treatment, 
whereas the number of B-2 cells in this compartment increased 
upon LPS treatment (Fig. 7). The results suggest that B-1a cells 
do not stay in the OMSs upon LPS stimulation, but enter other 
systemic sites, whereas B-2 cells are accumulated in the OMSs 
for the subsequent T-B cell interaction.
 
DISCUSSION
The localization of lymphocytes is determined by multiple fac-
tors including chemokines and adhesion receptors. B-1 cells are 
mainly retained in the peritoneal cavity, but they do recirculate, 
although to a lesser extent than B-2 cells, and require the spleen 
for their development and maintenance (7). Among many che-
mokines, CXCL13 and CXCL12 are especially important for B 
cell development and functions. CXCL13 is well established to be 
essential for the recruitment of B cells into follicular dendritic 
cells and the formation of B cell follicles (10, 18). Meanwhile, 
CXCL12 is rich in dark zone of the germinal center and the seg-
regation of CXCL12- and CXCL13-rich regions are responsible 
for the germinal center organization (19). Germinal center B 
cells are either CXCR4-positive or CXCR4-negative and the ex-
pression of CXCR4 determine the localization of germinal cen-
ter B cells in dark or light zones (20). These studies suggest that 
the dynamic regulation of B cell localization critically depends 
on the expression of CXCR4 and its signaling as well as those of 
CXCR5. For B-1 cells, it is interesting to ask whether CXCL12, 
CXCL13, and other chemokines are responsible for the perito-
neal localization of B-1 cells. Interestingly, both CXCL12 and 
CXCL13 were reported to be produced in the peritoneal cavity. 
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CXCL13 was shown to be produced by omental cells and peri-
toneal macrophages and CXCL12 was by mesothelial cells (15, 
21). Therefore, both chemokines seem to have roles in the B-1 
cell localization, but so far the differential functional roles of 
these chemokines are not well understood. It is intriguing that 
both B-1a and B-1b cells in the homeostatic condition showed 
a poor migratory response to CXCL12 with a good response to 
CXCL13. We interpreted that both B-1 cell types may be retained 
in the peritoneal cavity by prolonged CXCL12 stimulation, which 
does not induce the migration in chronic stimulatory status, but 
acts as a pro-adhesive and survival signal (22). In contrast, we 
thought that the responsiveness to CXCL13 may be maintained 
since the sufficient amount of CXCL13 is not present in the cav-
ity or the CXCL13 signaling is not exhaustive.
  The principal function of B-1 cells is the production of natural 
antibodies for the protection against common pathogens espe-
cially early in life, but more complex functions of B-1 cells are 
being recognized such as regulation of immune responses by 
secreting IL-10 and elicitation of delayed type hypersensitivity 
(6, 23). To perform these systemic functions, B-1a cell are re-
quired to leave the peritoneal cavity and enter into other periph-
eral sites. The systemic functions of B-1a cells are thought to be 
pro-inflammatory in one aspect and anti-inflammatory in other 
aspect. The locally produced natural antibody-antigen complex 
may activate the complement cascade and enhance the overall 
antigen presentation process, as exemplified in the role of B-1a 
cells in the elicitation of delayed type hypersensitivity (5). On 
the other hand, IL-10 produced in peripheral inflammatory sites 
by B-1a cells exerts a negative immune regulation (23). In con-
trast, B-1b cells were reported to perform a major role in the T 
cell-independent humoral IgM memory against microbial anti-
gens, but other functions of B-1b cells are not so well known (4). 
In our experiments, B-1b cells showed a migratory pattern that 
was intermediate between those of B-1a and B-2 cells, which 
may reflect differential functions of B-1b cells. We thought that 
the relationship between chemokines and their receptors should 
be differentially altered in B cell subsets when systemic inflam-
matory signals were present. The observation that B-1a cells mi-
grated out of the peritoneal cavity upon LPS treatment to a larger 
extent than B-1b and B-2 cells may be explained by a time re-
quirement to re-establish the steeply unequal distribution of 
B-1a cells after peritoneal B-1a cells were once released from the 
cavity and dispersed. B-2 and B-1b cells may re-enter the peri-
toneal cavity rapidly since these cells are more abundant in sys-
temic sites than B-1a cells. However, the concurrent changes in 
the migratory response of B-1a cells to CXCL12 as well as CXCL13 
and the surface expression of CXCR4 led us to presume that the 
migratory change may at least partially be mediated by the switch 
of chemokine-induced migratory responsiveness in B-1a cells 
upon LPS stimulation, which is more prominent than in B-1b 
and B-2 cells. 
  Distinct from other chemokines, CXCL12 perform important 
functions other than the migratory regulation of leukocytes. The 
CXCR4-CXCL12 pathway was reported to play essential roles in 
the maintenance of hematopoietic stem cells and long-lived 
plasma cells in bone marrow (24, 25). For developing B lineage 
cells, CXCL12 exerts different outcomes depending on the ex-
pression of SOCS3, which was low in progenitor B cells and the 
highest in mature B cells (22). CXCL12 induced prolonged focal 
adhesion kinase phosphorylation and sustained proadhesive 
responses in progenitor bone marrow B cells, but not in mature 
B cells (26). With regard to our results, we think that B-1a cells 
have some characteristics similar to progenitor B cells, which are 
chronically activated by pre-B cell receptor and CXCL12. We hy-
pothesized that B-1a cells also responded to prolonged CXCL12 
stimulation by adhesion to CXCL12-producing mesothelial cells, 
not by migration, in the homeostatic condition. Since B cell re-
ceptors (BCRs) of B-1a cells are basically autoreactive, constitu-
tive BCR-mediated signaling is also likely to contribute to the 
peritoneal localization of B-1a cells in the homeostatic condition 
(27, 28). According to our results, the interaction between B-1a 
cells and mesothelial cells appears to be greatly weakened by 
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LPS stimulation. At present, we do not know how LPS signaling 
breaks this interaction, but we think that the LPS effect may some-
how turn off the CXCR4 signaling pathway for adhesion and re-
lease B-1a cells from the peritoneal cavity with a heightened mi-
gratory sensitivity to chemokines for systemic migration. 
  The omentum is a bilayered sheet of mesothelial cells con-
necting the spleen, pancreas, stomach, and transverse colon 
and contains milky spots, which are clusters of macrophages, 
B-1 cells, and a few T cells embedded in the omental tissue (29). 
The number and size of OMSs increase with surgery and inflam-
mation and, therefore, the OMSs are thought to be sites for lym-
phocyte interaction and immune responses against peritoneal 
antigens (17, 30). Here we could observe that the number of B-1a 
cells in OMSs decrease upon LPS stimulation, which suggest 
that B-1a cells are not primarily participating in the T-B cell in-
teraction in this lymphoid tissue. However, B-2 cells were thought 
to participate in the local antibody responses since the number 
of B-2 cells increased upon LPS stimulation. 
  In summary, we here addressed how B-1a cells migrate to 
the systemic sites in inflammatory situations. Using LPS-treated 
mice, we showed that B-1a cells preferentially migrated out of 
the peritoneal cavity compared to B-1b and B-2 cells. Mechanis-
tically, B-1 cells showed a greatly increased migratory respon-
siveness to CXCL12 and CXCL13 after intraperitoneal injection 
of LPS. Since B-1a cells did not stay in the omentum upon the 
LPS injection, we interpreted that B-1a cells were actively migrat-
ing out of peritoneal cavity upon LPS stimulation and partici-
pate in the systemic immune responses. It is suggested that the 
intricate regulation of CXCR4 in B-1a cells may be a key to un-
derstand the dynamic behaviors of B-1a cells. 
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